Featured,Trends & Articles Advocates in Texas Pushing for Psychedelic Therapies Following Veteran Suicides Increase By Dennis Mutua April 25, 2022 A group of veteran advocates and organizations are pushing for the state governments to consider psychedelic treatments following an increase of veteran suicides in Texas. Citing recently released federal data, about 10 veterans f...
Psychedelic Stocks,Shroom News Maine Senate Approves Medical Psilocybin Proposal but House of Representatives Turns it Down By Dennis Mutua April 22, 2022 In the course of this week, the Maine Senate approved a medical psilocybin bill which is seeking to create a medical program across the state. However, the House of Representatives refused to pass the same bill. This bill was i...
Featured,Spotlight Stock COMPASS Pathways Partners With One Mind to Sponsor 2022 Awards for Next Generation of Mental Health Scientists By Dennis Mutua April 21, 2022 Mental health care company focusing on accelerating patient access to evidence-based innovation in mental health COMPASS Pathways Plc. (NASDAQ: CMPS) has entered into a partnership with One Mind to sponsor the ‘2022 One Mind- CO...
Psychedelic Stocks Fee Splitting and Ketamine Clinics: Doctors and MSOs Beware! By Dennis Mutua April 20, 2022 One of the primary restrictions that ketamine clinics run into when retaining a Management Services Organization (MSO) are fee-splitting prohibitions. Fee splitting is a state law concept and can vary from state to state. In some ...
Featured,Spotlight Stock Psyence and Filament Health Enter Into a Licensing Agreement for Natural Psilocybin Products By Dennis Mutua April 20, 2022 Life Science company fronting the use of natural psilocybin in mental health and well-being Psyence Group Inc. (CSE: PSYG) (OTCQB: PSYGF) has entered into an exclusive licensing agreement with Filament Health Corp. (NEO: FH) (OTCQ...
Psychedelic Stocks Ketamine Telehealth: An Update By Dennis Mutua April 19, 2022 Ketamine telehealth just got a big lifeline. On April 12, 2022, the Department of Health and Human Services (HHS) renewed its determination that a public health emergency (PHE) exists due to COVID-19. Obviously, this has been a hu...
Psychedelic Stocks,Shroom News MindMed Collaborators to Present Clinical Trial Results for LCD in Anxiety Disorder at PSYCH Symposium By Dennis Mutua April 19, 2022 Biopharmaceutical company developing psychedelics-inspired medicines and therapies to address addiction and brain health disorders MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced that its collaborators at University Hospital Bas...
Featured,Spotlight Stock Delic Labs Granted Permission to Study Psychedelics Compounds By Dennis Mutua April 18, 2022 Licensed cannabis and psilocybin research company focused on advanced research, testing and analysis for the psychedelic-wellness industry Delics Labs has been granted a section 56 exemption from Health Canada giving permission to...